Synapse Health Unveils Clinical-Grade Radiology LLM and Tops $85M Series A

AI · 5 min read

The LLM, branded as SynapseAI, integrates with PACS systems and radiology viewers to produce draft reports that highlight image regions, confidence scores, and links back to raw DICOM slices. Synapse Health emphasizes audited chain-of-evidence for each generated claim—capturing the image region, image metadata, and the reasoning trace used by the model.

Investors including MedTech Growth Partners and a consortium of hospital systems backed the $85 million round. Synapse Health plans to pursue FDA clearance pathways for clinical decision support in the US and regulatory alignment in Europe.

Pilot deployments at three academic hospitals report faster turnaround times for routine reads and fewer inconsistencies in report phrasing. Synapse is positioning the product as an assistant that drafts and cites, not a replacement for radiologists, and its roadmap includes bi-directional integration to capture clinician feedback as labeled data for continual improvement.